The global Enteric Softgel Capsules Market was valued at USD 2.4 Billion in 2022 and is projected to reach USD 3.1 Billion by 2030, growing at a CAGR of 4.2% from 2022 to 2030.

Enteric Softgel Capsules Market Overview:

Enteric softgel capsule made by enteric-coating method, which is a health product or medicine in oral dosage form. Going into softgel capsule coating involves the application of polymer coatings to softgel capsules to protect against various properties of the drug product or drug, such as pH, odor, and taste.

Enteric-coated softgel capsules are usually a combination of gelatin, glycerin or sorbitol, opacifiers, and water. However, manufacturers in the enteric-coated softgel market have been able to replace gelatin in softgel shells with other non-gelatin polymers, such as those manufactured using starch.

Enteric-coated softgel capsules market players provide uniformity of content, oral bioavailability, and liquid and semi-solid drug formulations by introducing high-quality enteric-coated softgel capsules. The growing popularity of softgel capsule drugs further encourages the manufacturers in the enteric coated softgel capsule market to invest in advanced manufacturing technologies to launch high quality enteric softgel capsules.

Enteric Softgel Capsules market size estimates and forecasts are provided in terms of sales volume (K units) and revenue (million USD), with historical and forecast data for the period 2017 to 2030, with 2022 being considered as the base year. This report segments the global Enteric Softgel Capsules market in detail. Regional market sizes related to products by type, by application, and by player are also delivered. In estimating the size of the market, we took into account the impact of COVID-19 and other global crisis.

The global Enteric Softgel Capsules market is the professional and accurate study of various business perspectives such as major key players, key geographies, divers, restraints, opportunities, and challenges. This global research report has been aggregated on the basis of various market segments and sub-segments associated with the global market.

Industry News and Key Developments

• In February 2019, ACG expanded its footprint in Brazil with the launch of its new capsules manufacturing plant in Pouso Alegre-Minas Gerais
• In February 2018, CapsCanada invested US$ 28 Mn in new 100,000 square foot K-CAPS facility with additional 50% capsule production increase; nearly 3-times the amount CapsCanada invested in a 2014 HPMC capsule expansion, to meet rising global demand for K-CAPS.
• In July 2017, Lonza completed the acquisition of Capsugel S.A. Under the agreement, Lonza paid US$ 5.5 Bn in cash, including refinancing of existing Capsugel debt of approximately US$ 2 Bn for the acquisition of Capsugel, a world leader in advanced oral dosage delivery technologies with a leading position in hard capsules.

Top Key Players include in the Enteric Softgel Capsules Market are
Aenova Group GmbH, BASF SE, Catalent, Inc., Colorcon Inc., Fuji Capsule Co., Ltd., Lonza Group AG, Now Health Group, Inc., ProCaps Group, Super Spectrim and Thermo Fisher Scientific, Inc. and others

The Enteric Softgel Capsules market research report is categorized based on type, applications and region.

On the Basis of Type:

• Gelatin Type
• Vegetable Type

On the Basis of Application:

• Antacid and Antiflatulent Preparations
• Antibiotic and Antibacterial Drugs

By Distribution Channel:

• Supermarkets and Hypermarkets
• Pharmacy and Drug Stores
• Online Stores

On the Basis of Region:

Geographically, the global Enteric Softgel Capsules market has been analyzed in various regions such as North America, Latin America, Middle East, Asia-Pacific, Africa, Europe, and India. The global Enteric Softgel Capsules region is dominating this market in the upcoming future.

Asia Pacific offers lucrative opportunities for players in the Enteric Softgel Capsules market owing to high population base, rising awareness about nutraceuticals, development of healthcare infrastructure, and increasing demand for Enteric Softgel Capsules.

Increasing geriatric population is one of the key reasons driving the consumption of enteric softgel capsule health products in the Asia-Pacific market. The ability to absorb needed nutrients decreases with age. As a result, people have turned to dietary supplements to bridge this gap. Moreover, large patient population in developing economies such as India and China and rising healthcare spending due to GDP growth are expected to create new opportunities over the forecast period. On the other hand, intense competition among market players can hamper the growth of the enteric softgel capsules market in Asia Pacific.

Further the regions are divided into countries as follows

• North America
• US
• Canada
• Mexico
• Rest of North America
• Europe
  • Denmark
  • Finland
  • Iceland
  • Sweden
  • Norway
  • Belgium
  • The Netherlands
  • Luxembourg
• Germany
• France
• Italy
• Spain
• UK
• Nordic Countries
• Benelux Union
• Rest of Europe
• Asia-Pacific
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Rest of Southeast Asia
• Japan
• China
• India
• Australia
• South Korea
• Southeast Asia
• Rest of Asia-Pacific
• The Middle East & Africa
• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest of the Middle East & Africa
• Latin America
• Brazil
• Argentina
• Rest of Latin America

Enteric Softgel Capsules Market report scope

Report Attributes	Details
Growth Rate	CAGR of 4.2% during the forecast period.
By Type	Gelatin Type, Vegetable Type
By Application	Antacid and Antiflatulent Preparations, Antibiotic and Antibacterial Drugs
By Companies	Aenova Group GmbH, BASF SE, Catalent, Inc., Colorcon Inc., Fuji Capsule Co., Ltd., Lonza Group AG, Now Health Group, Inc., ProCaps Group, Super Spectrim and Thermo Fisher Scientific, Inc. and others
Regions and Countries Covered	North America: (US, Canada, Mexico, Rest of North America) Europe(Germany, France, Italy, Spain, UK, Nordic Countries, Benelux Union, Rest of Europe) Asia-Pacific (Japan, China, India, Australia, South Korea, Southeast Asia, Rest of Asia-Pacific) The Middle East & Africa(Saudi Arabia, UAE, Egypt, South Africa, Rest of the Middle East & Africa) Latin America(Brazil, Argentina, Rest of Latin America) Rest Of the World
Base Year	2022
Historical Year	2017 to 2022
Forecast Year	2023 to 2030

 

The major key questions addressed through this innovative research report:

What are the major challenges in front of the global Enteric Softgel Capsules market?

Who are the key vendors of the global Enteric Softgel Capsules market?

What are the leading key industries of the global Enteric Softgel Capsules market?

Which factors are responsible for driving the global Enteric Softgel Capsules market?

What are the key outcomes of SWOT and Porter’s five analysis?

What are the major key strategies for enhancing global opportunities?

What are the different effective sales patterns?

What will be the global market size in the forecast period?

Any special requirements about this report, please let us know and we can provide custom report.